Henry Gonzalez Rivera, MD
Gastroenterology · San Juan, PRNPI 1770586265
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 78.8% of it on its own, with 29 other manufacturers making up the rest. Among gastroenterology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $165.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$27K
- Johnson & Johnson$3K
- Biogen$460
- EMD Serono, Inc.$449
- Gilead$410
- E.r. Squibb & Sons, L.L.C.$369
- plus $2K from 24 others
What the payments were for
- Consulting fees$7,79423%
- Speaking & faculty fees$17,49151%
- Travel & lodging$360%
- Food & beverage$8,77826%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 97 | $26,930 |
| Johnson & Johnson(2 entities) | 11 | $3,264 |
| Biogen | 10 | $460 |
| EMD Serono, Inc. | 4 | $449 |
| Gilead | 13 | $410 |
| E.r. Squibb & Sons, L.L.C. | 19 | $369 |
| Genentech USA, Inc. | 3 | $308 |
| Acadia Pharmaceuticals Inc | 2 | $250 |
| Olympus Latin America, Inc. | 2 | $231 |
| Mallinckrodt Enterprises LLC | 1 | $135 |
| Merck | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| Intercept Pharmaceuticals, Inc. | 5 | $117 |
| Organon | 5 | $112 |
| Medtronic | 2 | $111 |
| Madrigal Pharmaceuticals | 2 | $102 |
| Lilly USA, LLC | 3 | $100 |
| AstraZeneca | 1 | $94 |
| PBG Puerto Rico LLC | 5 | $92 |
| Sanofi | 1 | $90 |
| Amneal Pharmaceuticals LLC | 4 | $62 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $34 |
| Exact Sciences | 1 | $25 |
| Pfizer Pharmaceuticals LLC | 2 | $25 |
| Boehringer Ingelheim | 1 | $20 |
| Pfizer | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,179 in reported general payments places this provider in the 95th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $88,768 |
| XifaxanRifaximin | 14 | $46,045 |
| Mesalamine | 50 | $37,225 |
| LinzessLinaclotide | 47 | $32,784 |
| Sucralfate | 376 | $25,847 |
| SuprepSodium, Potassium,mag Sulfates | 174 | $20,508 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 169 | $13,706 |
| Dexlansoprazole DrDexlansoprazole | 39 | $10,306 |
| Glycopyrrolate | 240 | $9,542 |
| Dicyclomine Hcl | 423 | $7,829 |
| Famotidine | 1,022 | $7,110 |
| Colestipol Hcl | 118 | $6,893 |
| Omeprazole | 927 | $6,439 |
| Ursodiol | 49 | $5,818 |
| Pantoprazole Sodium | 415 | $4,450 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $26,930 | $32,78447 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 198 gastroenterology providers in Puerto Rico.
Other gastroenterology in San Juan
- Marcia Cruz CorreaSan Juan$62K
- Loscar SantiagoSan Juan$39K
- Hector LozanoSan Juan$28K
- Rafael Rodriguez LopezSan Juan$20K
- Alexis Gonzalez RiveraSan Juan$16K
- Sulimar Rodriguez SantiagoSan Juan$11K
- Esther TorresSan Juan$9K
- Yahaira Moreno DenizardSan Juan$9K
- Ricky Jimenez CarloSan Juan$8K
- Suzette Rivera MacmurraySan Juan$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.